PRTK - Paratek Pharmaceuticals Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript

Paratek Pharmaceuticals, Inc. (PRTK) Q4 2021 Earnings Conference Call March 14, 2022 08:30 ET Company Participants Sarah Higgins - Vice President, Finance, Controller and Principal Accounting Officer Evan Loh - Chief Executive Officer Adam Woodrow - President and Chief Commercial Officer Randy Brenner - Chief Development and Regulatory Officer Michael Bigham - Executive Chairman Conference Call Participants Thomas Yip - H.C. Wainwright Bert Hazlett - BTIG Presentation Operator Greetings and welcome to the Paratek Pharmaceuticals’ Full Year 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sarah Higgins, Vice President of Finance, Controller and Principal Accounting Officer. Thank you. You may begin. Sarah Higgins Good morning and welcome to Paratek’s year end 2021 earnings and corporate update conference call. A press release of the company’s financial results was issued earlier today and we have also posted slides

For further details see:

Paratek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call Transcript